Skip to main content
SpringerLink
Log in

Paediatric Peritoneal Mesothelioma

  • Chapter
  • First Online:
Rare Tumors In Children and Adolescents

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 1207 Accesses

Abstract

Malignant peritoneal mesothelioma is an aggressive and extremely rare paediatric tumour. To decide on the optimal treatment for individual patients and to try to increase our knowledge on this disease to understand its biological basis still represent great challenges for those involved with patient care, particularly paediatric oncologists. Treatment should rely on a multimodal approach. We suggest that advice should be taken from national rare tumour groups or international group such as the EXPERT (European cooperative study group for paediatric rare tumour).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderson KA, Hurley WC, Hurley BT et al (1985) Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer 56:273–276

    Article  PubMed  CAS  Google Scholar 

  • André N, Ratsimandresy R, Réguerre Y et al (2009) Paediatric malignant mesothelioma: the SFCE experience. Pediatr Blood Cancer 53:823

    Article  Google Scholar 

  • Antman KH, Ruxer RL Jr, Aisner J et al (1984) Mesothelioma following Wilms’ tumor in childhood. Cancer 54:367–369

    Article  PubMed  CAS  Google Scholar 

  • Cioffredi LA, Jänne P, Jackman D (2009) Treatment of peritoneal mesothelioma in pediatric patients. Pediatr Blood Cancer 1:127–129

    Article  Google Scholar 

  • Falchero L, Coiffier B, Guibert B et al (1996) Malignant mesothelioma of the pleura following radiotherapy for Hodgkin disease. Bull Cancer 83:964–968

    PubMed  CAS  Google Scholar 

  • Foster JM, Radhakrishna U, Govindarajan V et al (2010) Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma. World J Surg Oncol 8:88

    Article  PubMed  Google Scholar 

  • Fraire AE, Cooper S, Greenberg SD et al (1988) Mesothelioma of childhood. Cancer 62:838–847

    Article  PubMed  CAS  Google Scholar 

  • Gordon PL, Wilroy RS, Lasater OE et al (1995) Neoplasms in Proteus syndrome. Am J Med Genet 57:74–78

    Article  PubMed  CAS  Google Scholar 

  • Kashanskiy SV, André N (2010) Paediatric mésothelioma: is there such a disease? Bull Cancer 97:571–576

    PubMed  CAS  Google Scholar 

  • Kauffman SL, Stout AP (1964) Mesothelioma in children. Cancer 17:539–544

    Article  PubMed  CAS  Google Scholar 

  • Malamitsi-Puchner A, Dimitriadis D, Bartsocas C et al (1990) Proteus syndrome: course of a severe case. Am J Med Genet 35:283–285

    Article  PubMed  CAS  Google Scholar 

  • Margery J, Ruffié P (2008) Environmental cancer: malignant pleural mesothelioma. Bull Cancer 95:77–86

    PubMed  CAS  Google Scholar 

  • Milano E, Pourroy B, Rome A, Delarue A, Coze C, Gorincour G, Bouvier C, Braguer D, André N (2006) Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma. Anticancer Drugs 17:1231–1234

    Article  PubMed  CAS  Google Scholar 

  • Moore AJ, Parker RJ, Wiggins J (2008) Malignant mesothelioma. Orphanet J Rare Dis 3:34

    Article  PubMed  Google Scholar 

  • Moran CA, Albores-Saavedra J I, Suster S (2008) Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight cases. Histopathology 52:824–830

    Article  PubMed  CAS  Google Scholar 

  • Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G et al (1993) The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4:415–420

    Article  PubMed  CAS  Google Scholar 

  • Silberstein MJ, Lewis JE, Blair JD, Graviss ER, Brodeur AE (1983) Congenital peritoneal mesothelioma. J Pediatr Surg 18:243–245

    Article  PubMed  CAS  Google Scholar 

  • Simon GR, Verschraegen CF, Jänne PA et al (2008) Pemetrexed plus gemcitabine as first-linechemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol 26:3567–3572

    Article  PubMed  CAS  Google Scholar 

  • Stock RJ, Fu YS, Carter JR (1979) Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis. Cancer 44:914–919

    Article  PubMed  CAS  Google Scholar 

  • Terry NE, Fowler CL (2009) Benign cystic mesothelioma in a child. J Pediatr Surg 44:e9–e11

    Article  PubMed  Google Scholar 

  • Ugolini D, Neri M, Ceppi M et al (2008) Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat Res 658:162–167

    Article  PubMed  CAS  Google Scholar 

  • Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644

    Article  PubMed  CAS  Google Scholar 

  • Yan TD, Deraco M, Baratti D et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242

    Article  PubMed  Google Scholar 

  • You B, Blandin S, Gérinière L et al (2007) Mésothéliomes familiaux: une composante génétique associée aux risques environnementaux ? Bull Cancer 7:705–710

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Hématologie et Oncologie Pédiatrique, Hôpital pour enfants de “la Timone” AP-HM, Marseille, France

    Nicolas André

  2. Institute of Pathology, University Hospital of Erlangen, Erlangen, Germany

    Abbas Agaimy

Authors
  1. Nicolas André
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abbas Agaimy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas André .

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Klinikum Dortmund gGmbH, Beurhausstr. 40, Dortmund, 44137, Germany

    Dominik T. Schneider

  2. Klinik für Kinder und Jugendliche, Universitätsklinikum Erlangen-Nürnberg, Loschgestr. 15, Erlangen, 91054, Germany

    Ines B. Brecht

  3. at Egleston, Dept. Pediatric Hematology/Oncology, Children's Healthcare of Atlanta, Uppergate Drive NE., 2015, Atlanta, 30322, Georgia, USA

    Thomas A. Olson

  4. Unità di Oncologia Pediatrica, Istituto Nazionale Tumori, Via G. Venezian 1, Milano, 20133, Italy

    Andrea Ferrari

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

André, N., Agaimy, A. (2012). Paediatric Peritoneal Mesothelioma. In: Schneider, D., Brecht, I., Olson, T., Ferrari, A. (eds) Rare Tumors In Children and Adolescents. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04197-6_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04197-6_37

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04196-9

  • Online ISBN: 978-3-642-04197-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation